Formal syntheses of cryptophycin A and arenastatin A

Tetrahedron Letters

Volumn 38, Issue 10, 1997, Pages 1703-1706

  Ali, Syed M ^a,b   Georg, Gunda I ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARENASTATIN A; CRYPTOPHYCIN A; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CHEMICAL MODIFICATION; DRUG SYNTHESIS; HYDROGENATION; REACTION ANALYSIS;

EID: 0031562477     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)00194-9     Document Type: Article

References (25)

1. (2) Schwartz, R. E.; Hirsch, C. F.; Sesin, D. F.; Flor, J. E.; Chartrain, M.; Fromtling, R. E.; Harris, G. H.; Salvatore, M. J.; Liesch, J. M.; Yudin, K. J. Ind. Microbiol. 1990, 5, 113-124.
2. (3) Trimurtulu, G.; Ohtani, I.; Patterson, G. M. L.; Moore, R. E.; Corbett, T. H.; Valeriote, F. A.; Demchik, L. J. Am. Chem. Soc. 1994, 116, 4729-4737.
3. (4) Golakoti, T.; Ogino, J.; Heltzel, C. E.; Husebo, T. L.; Jensen, C. M.; Larsen, L. K.; Patterson, G. M. L.; Moore, R. E.; Mooberry, S. L.; Corbett, T. H.; Valeriote, F. A. J. Am. Chem. Soc. 1995, 117, 12030-12049.
4. (5) Smith, C. D.; Zhang, X.; Mooberry, S. L.; Patterson, G. M. L.; Moore, R. E. Cancer Res. 1994, 54, 3779-3784.
5. (6) Moore, R. E. In Abstracts of Papers, 209th National Meeting of the American Chemical Society; American Chemical Society: Anaheim, CA, 1995; ORG 215.
6. (7) Kerksiek, K.; Mejillano, M.; Schwartz, R. E.; Georg, G. I.; Himes, R. FEBS Letters 1995, 377, 59-61.
7. (8) Smith, C. D.; Zhang, X. J. Biol. Chem. 1996, 271, 6192-6198.
8. (9) Kobayashi, M.; Aoki, S.; Ohyabu, N.; Kuroso, M.; Wang, W.; Kitagawa, I. Tetrahedron Lett. 1994, 35, 7969-7972.
9. (10) Kobayashi, M.; Kuroso, M.; Ohyabu, N.; Wang, W.; Fujii, S.; Kitagawa, I. Chem. Pharm. Bull. 1994, 42, 2196-2198.
10. (11) Barrow, R. A.; Hemscheidt, T.; Liang, J.; Paik, S.; Moore, R. E.; Tius, M. A. J. Am. Chem. Soc. 1995, 117, 2479-2490.
11. (12) de Muys, J.-M.; Rej, R.; Go, B.; Fortin, S.; Lavallee, J.-F. Bioorg. Med. Chem. Lett. 1996, 6, 1111-1116.
12. (13) Rej, R.; Nguyen, D.; Go, B.; Fortin, S.; Lavallee, J.-F. J. Org. Chem. 1996, 61, 6289-6295.
13. (14) Salamonczyk, G. M.; Han, K.; Guo, Z.; Sih, C. J. J. Org. Chem. 1996, 61, 6893-6900.
14. (15) Kobayashi, M.; Kuroso, M.; Wang, W.; Kitagawa, I. Chem. Pharm. Bull. 1994, 42, 2394-2396.
15. (16) Kobayashi, M.; Wang, W.; Ohyabu, N.; Kurosu, M.; Kitagawa, I. Chem. Pharm. Bull. 1995, 43, 1598-1600.
16. (17) Georg, G. I.; Harriman, G. C. B.; Vander Velde, D. G.; Boge, T. C.; Cheruvallath, Z. S.; Datta, A.; Hepperle, M.; Park, H.; Himes, R. H.; Jayasinghe, L. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995; ACS Symposium Series 583, pp 217-232.
17. (18) Brooks, D. W.; Kellog, R. P.; Cooper, C. S. J. Org. Chem. 1987, 52, 192-196.
18. (19) Gunderson, L.-L.; Benneche, T.; Undheim, K. Acta Chem. Scand. 1989, 43, 706-709.
19. (20) For review, see Noyori, R. Asymmetric Catalysis in Organic Synthesis; Wiley & Sons: New York, NY, 1994, pp 56-94.
20. (21) Frater, G. Helv. Chim. Acta 1979, 62, 2825-2832.
21. (22) Georg, G. I.; Kant, J.; Gill, H. J. J. Am. Chem. Soc. 1987, 109, 1129-1135.
22. (23) Genet, J. P.; Ratovelomanana-Vidal, V.; Can de Andrade, M. C.; Pfister, X.; Guerreiro, P.; Lenoir, J. Y. Tetrahedron Lett. 1995, 36, 4801-4804.
23. (24) The ee was determined using a chiral column (DIACEL CHIRACEL OD-H). The mobile phase consisted of a 25:1 hexane/2-propanol mixture and the flow rate was 1 mL/min.
24. (25) For review, see: Ley, S. V.; Norman, J.; Griffith, W. P. Synthesis 1994, 639-666.
25. (26) Kocienski, P. J. Protecting Groups; Thieme: Stuttgart, 1994, pp 28-42.